iSonea is a leader in the development of mobile health devices for the management of asthma, COPD and other chronic breathing conditions. iSonea’s proprietary apps, software and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes and reduce healthcare expenditures.
Our mission is to:
- Improve management of asthma and other obstructive lung diseases by bringing innovative non-invasive acoustic respiratory monitoring technology to the market.
- Be competitive and dynamic by becoming a leading company in the field of pulmonary acoustics, thereby providing a satisfying workplace for our employees and value to our shareholders.
iSonea was founded through the merger of Karmelsonix of Israel and PulmoSonix of Australia. Through the merger, iSonea was able to use each company’s proprietary respiratory acoustic technology to offer solutions to previously unmet challenges of asthma monitoring and management.
The company was renamed iSonea Ltd. in August 2011.